Protein kinase C beta II suppresses colorectal cancer by regulating IGF-1 mediated cell survival

Despite extensive efforts, cancer therapies directed at the Protein Kinase C (PKC) family of serine/threonine kinases have failed in clinical trials. These therapies have been directed at inhibiting PKC and have, in some cases, worsened disease outcome. Here we examine colon cancer patients and show...

Descripción completa

Detalles Bibliográficos
Autores principales: Dowling, Catríona M., Phelan, James, Callender, Julia A., Cathcart, Mary Clare, Mehigan, Brian, McCormick, Paul, Dalton, Tara, Coffey, John C., Newton, Alexandra C., O'sullivan, Jacintha, Kiely, Patrick A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991501/
https://www.ncbi.nlm.nih.gov/pubmed/26989024
http://dx.doi.org/10.18632/oncotarget.8062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991501/
https://www.ncbi.nlm.nih.gov/pubmed/26989024
http://dx.doi.org/10.18632/oncotarget.8062

Ejemplares similares